Treating NETs via synthetic lethality
Michael German, MD
Finished Projects
Treating neuroendocrine tumors via synthetic lethality
Michael German, MD
Trends in incidence and survival outcomes for lung NETs
Claire Mulvey, MD
Tumor xenografts in zebrafish: a new in vivo model for lung carcinoids
Giovanni Vitale, MD, PhD
Tumor-specific delivery of temozolomide to overcome resistance in GEP-NETs
Ali Azhdarinia, PhD
UCHL1 as a minimally invasive molecular indicator for gastroenteropancreatic neuroendocrine tumors
Tanya Stoyanova, PhD
Uncovering the cellular mechanisms that limit clinical application of PRRT
Susanne Kossatz, PhD
Understanding the genetic and cellular origins of carcinoid cancer
Ramesh Shivdasani, MD, PhD
Understanding the physiologically relevant functions of DAXX
Guillermina (Gigi) Lozano, PhD
Understanding the tumor suppressor activities of ATRX-DAXX through epigenomic profiling and animal models
Peter Lewis, PhD; C. David Allis, PhD